10-K/A: Nutex Health Files Amendment No. 1 to Form 10-K for Fiscal Year Ended December 31, 2024

Nutex Health files an amendment to its annual report to include previously omitted information regarding directors, executive officers, corporate governance, executive compensation, security ownership, related person transactions, and principal accountant fees.

Summary

• Nutex Health Inc. filed Amendment No. 1 to its Form 10-K for the fiscal year ended December 31, 2024.
• The amendment includes information previously omitted from the original filing, specifically Items 10 through 14 of Part III of Form 10-K.
• This information pertains to directors, executive officers, corporate governance, executive compensation, security ownership, related person transactions, and principal accountant fees and services.
• The company is publicly disclosing this information prior to filing its definitive proxy statement.
• The amendment also includes new certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
• The aggregate market value of voting common stock held by non-affiliates at June 30, 2024 was approximately $18.2 million.
• As of March 24, 2025, there were 5,528,448 shares of common stock outstanding.

Sentiment

Score: 7

Explanation: The document is a standard regulatory filing, so the sentiment is neutral to slightly positive due to increased transparency.

Positives

• The company is providing greater transparency by disclosing previously omitted information about its leadership and governance.
• The company has a compensation recovery (clawback) policy in place.

Future Outlook

The Board may make changes to its leadership structure in the future as it deems appropriate.

Industry Context

This filing is a routine part of regulatory compliance for publicly traded companies, ensuring transparency for investors.

Comparison to Industry Standards

• The executive compensation arrangements appear typical for companies of similar size and complexity.
• The board composition and committee structure align with Nasdaq listing requirements and best practices in corporate governance.
• The audit and non-audit fees paid to Marcum LLP are within a reasonable range compared to other companies in the healthcare sector.

Related Party Transactions

• The company leases most of its hospital division facilities from real estate entities owned by related parties, with cash payments totaling $20.0 million during the year ended December 31, 2024.
• Micro Hospital Holding LLC, an affiliate controlled by the CEO, made advances to one of the company's hospital facilities, SE Texas ER, totaling $1.4 million on December 31, 2024.
• The Physician LLCs had outstanding obligations to their member owners, who are also Company stockholders, totaling $0.8 million at December 31, 2024.
• The company has outstanding obligations of contributions for facilities currently under construction totaling $1.6 million at December 31, 2024.
• Accounts receivable related party included $4.3 million at December 31, 2024 due from noncontrolling interest owners of consolidated hospital facilities.

Stakeholder Impact

• The filing provides greater transparency for shareholders regarding the company's leadership, governance, and executive compensation.
• Employees are impacted through the disclosure of executive compensation arrangements and benefit plans.
• The disclosure of related party transactions provides insight into potential conflicts of interest and the company's dealings with its executives and directors.

Key Dates

Keywords

executive compensation, corporate governance, directors, officers, Nutex Health, amendment, Form 10-K